mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.06 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.06 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.09 |
0.06 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.07 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.07 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.07 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.07 |